Lanzul (Lansoprazole)

Lansoprazole belongs to the proton pump inhibitor class. It binds irreversibly to the H+/K+ ATPase enzyme (the proton pump) on gastric parietal cells, blocking the final step of acid secretion. This inhibition lowers gastric acidity, allowing damaged tissues to heal and reducing reflux‑related discomfort.

The appropriate dose of Lanzul is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function and other clinical factors. Patients should follow the dosage instructions provided by their prescriber and not adjust the dose without medical guidance.

Safety data for lansoprazole in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Pregnant or nursing women should discuss treatment options with their healthcare provider.

To request Lanzul, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Lanzul (lansoprazole) is a proton pump inhibitor, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, its efficacy and safety profile are similar, though individual response and drug‑interaction potential may vary, making prescriber choice important.

Lanzul should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Lanzul is taken orally, usually as a whole tablet swallowed with water. It is generally recommended to take the dose before a meal, often in the morning, unless the prescriber advises otherwise. Patients should not crush or chew the tablet unless instructed.

Serious risks, though uncommon, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, liver enzyme elevations, low magnesium levels with prolonged use, and rare skin disorders like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, persistent diarrhea or muscle cramps.

Lanzul should be avoided in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is advised for patients with severe liver disease, those taking medications that may interact significantly, and for pregnant or nursing women unless clearly indicated by a healthcare professional.